A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
which is part of the UK Dementia Research Institute’s (UK DRI) Care Research & Technology Centre. Instead of taking one blood sample, as is the case in the majority of clinical practices, the ...
which is part of the UK Dementia Research Institute's (UK DRI) Care Research & Technology Centre. Instead of taking one blood sample, as is the case in the majority of clinical practices ...
One in four people are left to cope alone after a diagnosis with dementia, research has found. The study by The Alzheimer’s ...
Two bills providing a roadmap for federal efforts to respond to and fund Alzheimer’s research and programming unanimously passed in the US House of Representatives last week and now are awaiting ...
The Mātai Medical Research Institute will present the findings of its latest research projects on dementia and mental health ...
The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research led by ...
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...
Innovative treatments using TRIM21 have successfully targeted tau aggregates in Alzheimer’s, showing potential for broader ...
which is part of the UK Dementia Research Institute's (UK DRI) Care Research & Technology Centre. Instead of taking one blood sample, as is the case in the majority of clinical practices ...
The time of day when blood is taken can affect the results of tests for diagnosing dementia, according to new research.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback